Astegolimab or Efmarodocokin Alfa in Patients with Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial∗
- Michael Waters
- , James A. McKinnell
- , Andre C. Kalil
- , Greg S. Martin
- , Timothy G. Buchman
- , Wiebke Theess
- , Xiaoying Yang
- , Annemarie N. Lekkerkerker
- , Tracy Staton
- , Carrie M. Rosenberger
- , Rajita Pappu
- , Yehong Wang
- , Wenhui Zhang
- , Logan Brooks
- , Dorothy Cheung
- , Joshua Galanter
- , Hubert Chen
- , Divya Mohan
- , Melicent C. Peck*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations